| Dr Elza G Matrova, M D | |
|
601 N 30th St Ste 1609, Omaha, NE 68131-2137 | |
| (402) 280-3436 | |
| Not Available |
| Full Name | Dr Elza G Matrova |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 28 Years |
| Location | 601 N 30th St Ste 1609, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861756371 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| John H Stroger Jr Hospital | Chicago, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cook County | 2860398088 | 619 |
News Archive
Scientists at UC San Francisco, UC Berkeley and UCLA have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient's own blood-forming stem cells.
Intravenous administration of isotonic fluids is the standard emergency treatment in the U.S. for patients with severe blood loss, but UC San Diego bioengineering researchers have reported improved resuscitation with a radically different approach. Building on earlier studies in humans that have shown benefits of intravenous fluids that are eight times saltier than normal saline, the researchers combined hypertonic saline with viscosity enhancers that thicken blood.
A genetic pattern could predict how aggressive prostate cancer is before treatment, and whether the disease will come back in men who have already been treated, according to research published1 in the Lancet Oncology.
According to Australia's Ambassador on HIV/AIDS, Murray Proctor, Asia is falling short on HIV/AIDS treatment as almost 400,000 new cases are reported each year. He was attending a regional conference on universal access to treatment for AIDS where he said availability and price of vital anti-retroviral or anti- HIV medications remain a challenge for the region.
› Verified 2 days ago
| Entity Name | Cook County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588612832 PECOS PAC ID: 2860398088 Enrollment ID: O20031209000747 |
News Archive
Scientists at UC San Francisco, UC Berkeley and UCLA have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient's own blood-forming stem cells.
Intravenous administration of isotonic fluids is the standard emergency treatment in the U.S. for patients with severe blood loss, but UC San Diego bioengineering researchers have reported improved resuscitation with a radically different approach. Building on earlier studies in humans that have shown benefits of intravenous fluids that are eight times saltier than normal saline, the researchers combined hypertonic saline with viscosity enhancers that thicken blood.
A genetic pattern could predict how aggressive prostate cancer is before treatment, and whether the disease will come back in men who have already been treated, according to research published1 in the Lancet Oncology.
According to Australia's Ambassador on HIV/AIDS, Murray Proctor, Asia is falling short on HIV/AIDS treatment as almost 400,000 new cases are reported each year. He was attending a regional conference on universal access to treatment for AIDS where he said availability and price of vital anti-retroviral or anti- HIV medications remain a challenge for the region.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elza G Matrova, M D 13144 C Plz, Omaha, NE 68144-5307 Ph: (602) 410-1499 | Dr Elza G Matrova, M D 601 N 30th St Ste 1609, Omaha, NE 68131-2137 Ph: (402) 280-3436 |
News Archive
Scientists at UC San Francisco, UC Berkeley and UCLA have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient's own blood-forming stem cells.
Intravenous administration of isotonic fluids is the standard emergency treatment in the U.S. for patients with severe blood loss, but UC San Diego bioengineering researchers have reported improved resuscitation with a radically different approach. Building on earlier studies in humans that have shown benefits of intravenous fluids that are eight times saltier than normal saline, the researchers combined hypertonic saline with viscosity enhancers that thicken blood.
A genetic pattern could predict how aggressive prostate cancer is before treatment, and whether the disease will come back in men who have already been treated, according to research published1 in the Lancet Oncology.
According to Australia's Ambassador on HIV/AIDS, Murray Proctor, Asia is falling short on HIV/AIDS treatment as almost 400,000 new cases are reported each year. He was attending a regional conference on universal access to treatment for AIDS where he said availability and price of vital anti-retroviral or anti- HIV medications remain a challenge for the region.
› Verified 2 days ago
Audrey J Lazenby, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4186 Fax: 402-559-6018 | |
Shane K. Kohl, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4540 Fax: 402-354-4535 | |
Stanley J Radio, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 988102 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-4186 Fax: 402-559-6018 | |
Christine Petricek Hans, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4540 Fax: 402-354-4535 | |
Dr. Diana L Nevins, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4540 Fax: 402-354-4535 | |
Dr. Marc R Hapke, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 909 N 96th St, Suite 201, Omaha, NE 68114 Phone: 402-330-4555 Fax: 402-934-0945 | |
Bryan Scott Teruya, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 4101 Woolworth Ave, Department Of Pathology, Omaha, NE 68105 Phone: 402-995-3218 |